SEC Tracker
Get the app
CBLL · XBRL financial data

CeriBell financial statements, every quarter

The same tables from 9 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CBLL's year ends in late December)

In thousands of dollarsSep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers17,19518,534*20,49121,19922,58924,784*26,49428,09729,341
Cost of revenue2,1842,296*2,4842,5172,6473,141*3,3722,1593,001
Gross profit15,01116,238*18,00718,68219,94221,643*23,12225,93826,340
Research and development3,3953,913*4,2464,8524,9835,062*6,1616,7477,403
General and administrative9,0299,966*9,93511,36011,03712,119*15,31614,75714,453
Total operating expenses24,94829,122*32,21433,63434,58936,239*43,86745,91946,888
Operating income (loss)(9,937)(12,884)*(14,207)(14,952)(14,647)(14,596)*(20,745)(19,981)(20,548)
Interest expense530499*471477480462*434438267
Other income (expense)2231,886*1,9011,7861,6621,531*1,4421,151(536)
Income tax expense (benefit)—year only—000*—00
Net income (loss)(10,417)(12,576)*(12,777)(13,643)(13,465)(13,527)*(19,737)(19,268)(21,351)
Earnings per share, basic USD per share(1.85)—(0.36)(0.38)(0.37)(0.36)*(0.52)(0.51)(0.55)
Earnings per share, diluted USD per share(1.85)—(0.36)(0.38)(0.37)(0.36)*(0.52)(0.51)(0.55)
Weighted average shares, basic thousands of shares5,635—35,88136,29436,80737,170*37,66338,03238,500
Weighted average shares, diluted thousands of shares5,635—35,88136,29436,80737,170*37,66338,03238,500

Balance sheet

CSV

Fiscal quarters (CBLL's year ends in late December)

In thousands of dollarsSep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents14,110194,370153,36040,14123,73940,47645,25232,66341,989
Marketable securities——29,340137,287144,803118,78595,93296,59875,478
Accounts receivable9,97310,87811,29912,31212,23415,05315,71215,99517,792
Inventory6,9106,9376,5536,0006,0247,2886,9026,7376,955
Prepaid and other current assets2,2663,2502,8472,0222,8592,9062,8823,6582,991
Total current assets34,960217,272205,420199,786191,806186,718168,911157,847147,437
Property and equipment, net2,2682,3132,1252,1052,0552,0301,9261,7601,774
Right-of-use asset2,3652,1321,8941,6521,4052,2962,0411,7811,516
Total assets47,059225,412213,471207,689199,525195,803178,078166,348156,370
Accounts payable2,7761,1431,3702,4412,1822,8381,9813,1852,334
Accrued liabilities8,57410,0528,30110,42610,90714,32812,56112,48114,059
Total current liabilities13,08912,98911,83115,01415,16819,19016,18417,20018,034
Lease liability, non-current1,5991,3141,0237264221,3601,058748432
Total liabilities35,62934,24732,59035,53435,44440,46737,26538,03538,833
Accumulated deficit(154,368)(166,944)(179,721)(193,364)(206,829)(220,356)(240,093)(259,361)(280,712)
Total stockholders' equity(135,982)191,165180,881172,155164,081155,336140,813128,313117,537
Total liabilities and equity47,059225,412213,471207,689199,525195,803178,078166,348156,370
Common shares outstanding (cover page) thousands of shares35,82435,86836,14336,66437,09637,64137,94338,37838,835

Cash flows

CSV

Fiscal quarters (CBLL's year ends in late December)

In thousands of dollarsSep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(10,417)(12,576)*(12,777)(13,643)(13,465)(13,527)*(19,737)(19,268)(21,351)
Stock-based compensation1,376*2,202*2,3483,167*3,349*3,359*3,7235,998*7,099*
Depreciation and amortization243*364*335324*391*291*239245*249*
Net cash from operating activities(8,542)*(9,975)*(11,403)(7,533)*(11,098)*(10,774)*(19,297)(12,863)*(13,078)*
Purchases of property and equipment567*357*14871*369*179*12517*100*
Net cash from investing activities183*(493)*(29,609)(107,692)*(6,944)*26,108*22,441(606)*20,824*
Net cash from financing activities(1,888)*190,728*22,006*1,640*1,403*1,632880*1,580*
Net change in cash(10,247)*180,260*(41,010)(113,219)*(16,402)*16,737*4,776(12,589)*9,326*

Compare with peers

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Ceribell41,98929,341(13,078)*38.8M9.0 quarters 10-QSep 30, 2026
Delcath Systems47,52129,1335,712*34.7M— 10-QJun 30, 2026
Axogen328,88875,83416,536*59.7M— 10-QSep 30, 2026
Angiodynamics33,97380,915(15,330)42.1M2.2 quarters 10-QAug 31, 2026
Orthofix Medical103,810210,933(6,224)*40.7M16.7 quarters 10-QJun 30, 2026
Pulse Biosciences101,620434(18,709)*71.3M5.4 quarters 10-QJun 30, 2026
Butterfly Network122,30132,598(2,266)*not reported10.3 quarters 10-QSep 30, 2026
Orthopediatrics17,14172,6614,506*26.1M— 10-QSep 30, 2026
Iradimed63,28824,2036,997*12.8M— 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.